Wednesday, July 26, 2017 11:47:33 AM
IPIX has 5 trials ongoing in Phase II with final results for all expected by year end and yet some are crying about nothing going on and mgt sitting on their butts taking a break.
Most anyone with half a brain expects some very lucrative partnerships signed by end of year and yet we repeatedly get the same ol' dire financial warnings - that might have played a year or two ago but now is a nonsensical joke.
Our next trials highlight is the upcoming Prurisol interim data - to date we know there has been no AER's in the recent 300/400 dosage arms per statements by mgt,past arms have shown the drug to be highly dosage dependent so results should show much better results than in the weaker arms, and mgt has been adding trial sights to help speed up the completion of the trial yet some are acting as though the results are highly likely to be marginal at best. Obviously these types are not statisticians as the odds from where I sit are tilted quite heavily to extremely positive results.
Then, as a slap in the face to many, we hear these dire warnings are for our own good since those making them are actually share holders themselves. That's about as believable as movie stars talking about wanting a socialistic state for the US while they live in their multi-million dollar mansions and jet across the land in their private jets.
I wish admin here could put a big "Bullsh!t Alert" stamped on all posts that fly in the face of reality. But this is the US, we don't want to rain on anybody's parade so we all have to listen to the game players.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM